The authors reported industry ties for 69% of the 29-member DSM-5 task force and examined 141 members across 13 panels. They compared the task-force figure with 57% for DSM-IV and documented a persistent disclosure and conflict-of-interest concern.
Currently, 69% of the DSM-5 task force members report having ties to the pharmaceutical industry. This represents a relative increase of 21% over the proportion of DSM-IV task force members with such ties (57% of DSM-IV task force members had ties).
The authors reported industry ties for 69% of the 29-member DSM-5 task force and examined 141 members across 13 panels. They compared the task-force figure with 57% for DSM-IV and documented a persistent disclosure and conflict-of-interest concern. The 69% and 57% figures concern task-force members; the 141 people analyzed separately were members of 13 panels. Financial associations do not establish causation of diagnostic content.